|
Volumn 3 Suppl 2, Issue , 1996, Pages
|
Preliminary clinical experience with AMI 227.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTRAST MEDIUM;
DIAGNOSTIC AGENT;
IRON;
OXIDE;
ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
HALF LIFE TIME;
HUMAN;
LIVER;
LYMPH NODE;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
REFERENCE VALUE;
SPLEEN;
ADULT;
CONTRAST MEDIA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HALF-LIFE;
HUMANS;
IRON;
LIVER;
LYMPH NODES;
MAGNETIC RESONANCE IMAGING;
MALE;
OXIDES;
REFERENCE VALUES;
SPLEEN;
MLCS;
MLOWN;
|
EID: 0030210463
PISSN: 10766332
EISSN: None
Source Type: Journal
DOI: 10.1016/s1076-6332(96)80561-7 Document Type: Article |
Times cited : (8)
|
References (0)
|